Exelixis Inc Sustainability Reports
Exelixis Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of innovative cancer therapies.
Sector: Health Care
Country: United States
Exchange: Nasdaq Stock Market
ISIN: US30161Q1040
29 reports from 2000 to 2025